207 related articles for article (PubMed ID: 31545451)
1. Gene expression and prognosis of insulin‑like growth factor‑binding protein family members in non‑small cell lung cancer.
Wang J; Hu ZG; Li D; Xu JX; Zeng ZG
Oncol Rep; 2019 Nov; 42(5):1981-1995. PubMed ID: 31545451
[TBL] [Abstract][Full Text] [Related]
2. Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer.
Zeng Z; Yang Y; Qing C; Hu Z; Huang Y; Zhou C; Li D; Jiang Y
Medicine (Baltimore); 2020 Mar; 99(10):e19451. PubMed ID: 32150102
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Values of the Insulin-Like Growth Factor Binding Protein Family in Ovarian Cancer.
Zheng R; Chen W; Xia W; Zheng J; Zhou Q
Biomed Res Int; 2020; 2020():7658782. PubMed ID: 33282953
[TBL] [Abstract][Full Text] [Related]
4. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
5. Expression, Prognosis and Gene Regulation Network of NFAT Transcription Factors in Non-Small Cell Lung Cancer.
Ma J; Du R; Huang Y; Zhong W; Gui H; Mao C; Song X; Lu J
Pathol Oncol Res; 2021; 27():529240. PubMed ID: 34257525
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of 17‑β‑hydroxysteroid dehydrogenase type 2 and its prognostic significance in non‑small cell lung cancer.
Drzewiecka H; Jarmołowska-Jurczyszyn D; Kluk A; Gałęcki B; Dyszkiewicz W; Jagodziński PP
Int J Oncol; 2020 Jun; 56(6):1352-1372. PubMed ID: 32236582
[TBL] [Abstract][Full Text] [Related]
7. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
Hou GX; Liu P; Yang J; Wen S
PLoS One; 2017; 12(3):e0174515. PubMed ID: 28355294
[TBL] [Abstract][Full Text] [Related]
8. Distinct Prognostic Values of Phospholipase C Beta Family Members for Non-Small Cell Lung Carcinoma.
Zhang T; Song X; Liao X; Wang X; Zhu G; Yang C; Xie X
Biomed Res Int; 2019; 2019():4256524. PubMed ID: 31080817
[TBL] [Abstract][Full Text] [Related]
9. Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer.
Xiong J; Zhang X; Chen X; Wei Y; Lu DG; Han YW; Xu J; Yu D
Oncotarget; 2017 Feb; 8(8):13157-13165. PubMed ID: 28061457
[TBL] [Abstract][Full Text] [Related]
10. The prognostic values of insulin-like growth factor binding protein in breast cancer.
Wang J; Luo XX; Tang YL; Xu JX; Zeng ZG
Medicine (Baltimore); 2019 May; 98(19):e15561. PubMed ID: 31083221
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.
Kim JS; Kim ES; Liu D; Lee JJ; Solis L; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee HY
Clin Lung Cancer; 2014 May; 15(3):213-21. PubMed ID: 24485233
[TBL] [Abstract][Full Text] [Related]
12. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
13. [Expression of KIF23 and Its Prognostic Role in Non-small Cell Lung Cancer:
Analysis Based on the Data-mining of Oncomine].
Ye L; Li H; Zhang F; Lv T; Liu H; Song Y
Zhongguo Fei Ai Za Zhi; 2017 Dec; 20(12):822-826. PubMed ID: 29277180
[TBL] [Abstract][Full Text] [Related]
14. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
Feng A; Tu Z; Yin B
Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
[TBL] [Abstract][Full Text] [Related]
15. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
16. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
[TBL] [Abstract][Full Text] [Related]
17. A Protective Role for RHOJ in NonSmall Cell Lung Cancer Based on Integrated Bioinformatics Analysis.
Zeng T; Chen C; Yang P; Zuo W; Liu X; Zhang Y
J Comput Biol; 2020 Jul; 27(7):1092-1103. PubMed ID: 31638412
[TBL] [Abstract][Full Text] [Related]
18. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
[TBL] [Abstract][Full Text] [Related]
19. Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.
Stewart RL; West D; Wang C; Weiss HL; Gal T; Durbin EB; O'Connor W; Chen M; O'Connor KL
Hum Pathol; 2016 Aug; 54():174-83. PubMed ID: 27107458
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of Prognostic Value and Immune Infiltration of IGFBP Family Members in Glioblastoma.
Zhong Z; Xu X; Han S; Shao Y; Yi Y
J Healthc Eng; 2022; 2022():2929695. PubMed ID: 35832140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
